Mismatched family member stem cell donor
Showing 1 - 25 of >10,000
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,
Not yet recruiting
- End Stage Kidney Disease
- +3 more
- Donor CD34+, CD3+. and belumosudil
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Apr 6, 2023
Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)
Recruiting
- Living Donor Kidney Transplantation
- Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
-
Palo Alto, California
- +1 more
May 6, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- BPX-501 dose 1
- +5 more
-
Atlanta, Georgia
- +7 more
Jul 10, 2022
Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,
Active, not recruiting
- Acute Lymphoid Leukemia (ALL)
- +5 more
- Hyperfractionated total body irradiation
- +9 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)
Active, not recruiting
- Hematologic Malignancy
- melphalan
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,
Completed
- Leukemia, Acute Lymphocytic (ALL)
- +7 more
- CliniMACS
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 3, 2020
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,
Terminated
- Related Donors Donating PBSC to a Family Member
- +4 more
- MGTA-145
- Plerixafor
-
Duarte, California
- +7 more
Apr 13, 2022
Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,
Completed
- Acute Myeloid Leukemia
- Advanced Myelodysplastic Syndromes
- Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Aug 27, 2021
Ovarian Cancer Recurrent Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion)
Recruiting
- Ovarian Cancer Recurrent
- microtransplantation, HLA-mismatched donor peripheral stem cell infusion
-
Beijing, Beijing, ChinaThe third medical center of PLA General Hospital
Oct 26, 2021
Adult Acute Myeloid Leukemia Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion,
Recruiting
- Adult Acute Myeloid Leukemia
- microtransplantation, HLA-mismatched donor peripheral stem cell infusion
- +2 more
-
Beijing, Beijing, ChinaThe fifth medical center of PLA General Hospital
Feb 21, 2022
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial run by the NHLBI (Miltenyi
Completed
- Leukemia, Myeloid, Acute
- +2 more
- Miltenyi Magnetic cell sorter for CD3
-
Bethesda, MarylandNational Institutes of Health
Oct 7, 2020
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Leukemia
- +6 more
- Cyclophosphamide
- +8 more
- (no location specified)
Dec 8, 2021
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Solid Tumors Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion)
Recruiting
- Solid Tumors
- microtransplantation, HLA-mismatched donor peripheral stem cell infusion
-
Beijing, Beijing, ChinaBeijing Fengtai You'anmen Hospital
Jun 16, 2021
Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)
Active, not recruiting
- Leukemia
- +3 more
- Palifermin
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 23, 2023
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Sickle Cell Disease Trial in United States (CD34 selected T-cell depleted allogeneic SCT)
Active, not recruiting
- Sickle Cell Disease
- CD34 selected T-cell depleted allogeneic SCT
-
Los Angeles, California
- +5 more
Sep 27, 2022
DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors
Completed
- Hematologic Diseases
- Stem Cell Transplant Complications
-
Ancona, Italy
- +24 more
Aug 19, 2021
Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation
Completed
- Leukemia
- +2 more
- CliniMACS Fractionation system (Arm A)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 12, 2022
Myeloid Malignancies Trial in Italy (GvHD prophylaxis)
Recruiting
- Myeloid Malignancies
- GvHD prophylaxis
-
Alessandria, Italy
- +32 more
Nov 23, 2022
AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)
Recruiting
- AML - Acute Myeloid Leukemia
- +5 more
- T-allo10
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)
Terminated
- Acute Myeloid Leukemia
- +2 more
- ATIR101
- +3 more
-
Duarte, California
- +41 more
Apr 28, 2022